Asa Valenti

Asa Valenti, MBA, LLM, currently serves as the Senior Director of Business Development at Mineralys Therapeutics, Inc., beginning in August 2024. Prior experience includes roles as Director of Business Development at Fusion Pharmaceuticals and Acceleron Pharma, and Chief Business Officer at Dorna Therapeutics, a company focused on immuno-oncology and the development of a universal therapeutic cancer vaccine. Earlier in the career, Asa Valenti worked as a Partner in Venture Investments & Partnerships at Flex, and as a Corporate Development Manager at Johnson & Johnson, specializing in in-licensing, mergers and acquisitions, and research collaborations. Additional positions include contributions as an Associate in private equity and strategic alliances, and early experience in mergers and acquisitions and corporate law. Asa Valenti holds an MBA from the University of Virginia Darden School of Business and an LLM from the University of Pennsylvania Carey Law School.